Cargando…
The use of immunotherapy in the treatment of melanoma
Patients with advanced melanoma have a compromised anti-tumor immune response leading to tumor immune tolerance and a tumor microenvironment conducive to disease progression. Immunotherapy that successfully overcomes this tumor-mediated immune suppression has made the greatest impact in the manageme...
Autores principales: | Achkar, Tala, Tarhini, Ahmad A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402170/ https://www.ncbi.nlm.nih.gov/pubmed/28434398 http://dx.doi.org/10.1186/s13045-017-0458-3 |
Ejemplares similares
-
A Tumor and Immune-Related Micro-RNA Signature Predicts Relapse-Free Survival of Melanoma Patients Treated with Ipilimumab
por: Kobeissi, Iyad, et al.
Publicado: (2023) -
Systemic adjuvant therapy for high-risk cutaneous melanoma
por: Kobeissi, Iyad, et al.
Publicado: (2022) -
Immunotherapy for Melanoma: The Significance of Immune Checkpoint Inhibitors for the Treatment of Advanced Melanoma
por: Fujimura, Taku, et al.
Publicado: (2022) -
Adjuvant Therapy for High-Risk Melanoma: An In-Depth Examination of the State of the Field
por: Eljilany, Islam, et al.
Publicado: (2023) -
Novel anti-melanoma treatment: focus on immunotherapy
por: Hao, Meng-Ze, et al.
Publicado: (2014)